Trastuzumab and Vinorelbine in Advanced Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: trastuzumab|DRUG: vinorelbine
Sponsor: Dana-Farber Cancer Institute
Collaborators: Brigham and Women's Hospital|Beth Israel Deaconess Medical Center|Massachusetts General Hospital|Genentech, Inc.